JP Morgan Chase’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$639K Buy
12,404
+5,062
+69% +$261K ﹤0.01% 5053
2026
Q2
$377K Sell
7,342
-73
-1% -$3.5K ﹤0.01% 5264
2026
Q1
$300K Buy
7,415
+313
+4% +$13.5K ﹤0.01% 5281
2025
Q4
$285K Buy
7,102
+641
+10% +$25.4K ﹤0.01% 5345
2025
Q3
$255K Buy
6,461
+331
+5% +$12.2K ﹤0.01% 5385
2025
Q2
$228K Buy
6,130
+286
+5% +$9.7K ﹤0.01% 5171
2025
Q1
$196K Buy
+5,844
New +$206K ﹤0.01% 5249

Other funds holding CPAI

JP Morgan Chase's CPAI Position: Q3 2026 in Review

JP Morgan Chase increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 69% in Q3 2026, buying an estimated $261K and bringing the position to 12,404 shares worth $639K. The position accounts for ﹤0.01% of the portfolio, ranked #5053.

JP Morgan Chase first reported a position in CPAI in Q1 2025 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold CPAI as of Q3 2026.

  • JP Morgan Chase held 12,404 shares of Counterpoint Quantitative Equity ETF worth $639K as of Q3 2026.
  • JP Morgan Chase bought 5,062 Counterpoint Quantitative Equity ETF shares in Q3 2026, an estimated $261K.
  • Counterpoint Quantitative Equity ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5053 holding.
  • JP Morgan Chase first reported a position in Counterpoint Quantitative Equity ETF in Q1 2025 and has held it in 7 quarters since.
  • 64 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.